A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
Am J Gastroenterol. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Esomeprazole 40 mg compared with lansoprazole 30 mg in the treatment of erosive esophagitis.
Efficacy of esomeprazole 40 mg vs. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. How well can quantitative hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci. Transient lower esophageal sphincter relaxation. Randomized comparative study of omeprazole and famotidine in reflux esophagitis. J Gastroenterol Hepatol. Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.
Scand J Gastroenterol Suppl. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease.
Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U. Federal Government.
Read our disclaimer for details. Last Update Posted : June 26, Study Description. The aim of this trial is to evaluate the complete remission of erosive gastroesophageal reflux disease with pantoprazole magnesium 40 mg once daily versus esomeprazole 40 mg once daily during four-week treatment with an extension treatment for non-responding patients.
The study will provide further data on safety and tolerability of pantoprazole magnesium. FDA Resources. Arms and Interventions. Outcome Measures. Goals: To compare the efficacy of pantoprazole and esomeprazole with regard to healing and relief from gastroesophageal reflux disease-related symptoms.
Study: Multicenter, randomized, double-blind study. Healing endoscopy and relief from gastroesophageal reflux disease-related symptoms direct questioning were assessed at first and final visit after 4, 6, 8, or 10 weeks of treatment.
0コメント